한국직업건강간호학회지 (Korean Journal of Occupational Health Nursing)

  • 제19권1호
  • /
  • Pages.88-96
  • /
  • 2010
  • /
  • 2287-2531(pISSN)
  • /
  • 2466-1856(eISSN)
한국직업건강간호학회 (Korean Academic Society of Occupational Health Nursing)
권호 표지

유해화학물질 노출 근로자의 대사증후군 발생위험에 대한 epinephrine과 norepinephrine의 영향

Influence of Epinephrine and Norepinephrine on the Risk of Metabolic Syndrome Occurrence in Workers Exposed to Hazardous Chemicals

  • 허경화 (한국산업안전보건공단 산업안전보건연구원) ;
  • 김기웅 (한국산업안전보건공단 산업안전보건연구원)
  • Heo, Kyung-Hwa (Occupational Safety and Health Research Institute, Korea Occupational Safety and Health Agency) ;
  • Kim, Ki-Woong (Occupational Safety and Health Research Institute, Korea Occupational Safety and Health Agency)
  • 투고 : 2010.04.06
  • 심사 : 2010.05.25
  • 발행 : 2010.05.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Purpose: The aim of the present study was to clarify effects of long term, low-level monocyclic aromatic hydrocarbons exposure (MAHs) such as styrene, toluene and xylene on physiological levels of epinephrine (EP) and norepinephrine (NEP) and these hormones influences diagnosis indices of metabolic syndrome (MetS). Methods: Blood pressure and serum biochemical parameters were measured using digital sphygmomanometer and autochemical analyzer. EP and NEP were analyzed by using ELISA kit and exposure level of MAHs was measured by NIOSH method. Results: The differences of general characteristics such as age, smoking and drinking habits in both groups were not significantly different except working hours per day. In exposed workers, exposure levels of MAHs showed very low concentrations. Serum HDL-cholesterol concentration was significantly higher in exposed group, but concentration of NEP was significantly higher in control group. On multiple logistic regression analysis for the diagnosis indices of MetS, EP was WC (OR=0.970), NEP was blood pressure (OR=1.002) and MAHs exposure were significantly associated with HDL-cholesterol (OR=0.257), fasting glucose (OR=3.028) and MetS (OR=0.372). Conclusion: These findings suggest that the chronic exposure of low level MAHs maycontribute to glucose metabolism and induction of MetS. And also, changes of EP and NEP levels by exposure of MAHs affect blood pressure.

키워드

참고문헌

  1. 이현진 (2007). 보건소 비만 프로그램을 통한 성인 여성의 체지방 변화에 따른 건강상태 및 식생활 비교. 단국대학교 대학원 석사학위논문.
  2. 허경화, 구정완, 원용림, 김민기, 고경선, 이미영, 김태균, 김기웅 (2009). 만성적인 스티렌 노출 근로자에 있어 대사증후군 유발에 관여하는 위험요인의 생리적 수준 변화. 한국산업위생학회지, 19, 30-38.
  3. Albright, J. A., & Goldstein, R. A. (1996). Airborne pollutants and the immune system. Atolaryngology-Head and Neck Surgery, 114, 232-238. https://doi.org/10.1016/S0194-5998(96)70173-0
  4. Ames, A. (2000). CNS energy metabolism as regulated to function. Brain Res Rev, 34, 42-68. https://doi.org/10.1016/S0165-0173(00)00038-2
  5. Bao. X., Lu, C. M., Liu, F., Gu, Y., Dalton, N. D., Zhu, B. Q., Foster, E., Chen, J., Karliner, J. S., Ross, J. Jr., Simpson, P. C., & Ziegler, M. G. (2007). Epinephrine is required for normal cardiovascular responses to stress in the phenylethanolamine N-methyltransferase knockout mouse. Circulation, 116(9), 1024-1031. https://doi.org/10.1161/CIRCULATIONAHA.107.696005
  6. Carvalho, D., Lanchote, V. L., Bonato, P. S., Queiroz, R., Santos, A. C., & Dreossi, S. (1991). A new derivatization procedure for the analysis of hippuric acid and methyl hippuric acid by gaschromatography. Int Arch Occup Environ Health, 63, 33-37. https://doi.org/10.1007/BF00406195
  7. Chakrabarti, S. K. (1999). Styrene and styrene oxide affect the transport of dopamine in purified rat striatal synaptic vesicles. Biochem Biophys Res Commun, 255, 70-74. https://doi.org/10.1006/bbrc.1998.9935
  8. Cryer, P. E. (1993). Glucose counterregulation: Prevention and correction of hypoglycemia in humans. Am J Physiol, 264, E149-155.
  9. DeFronzo, R. A., & Ferrannini, E. (1991). Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care, 14, 173-194. https://doi.org/10.2337/diacare.14.3.173
  10. Gillis, B., Gavin, I. M., Arbieva, Z., King, S. T., Jayaraman, S., & Prabhakar, B. S. (2007). Identification of human cell responses to benzene and benzene metabolites. Genomics, 90, 324-333. https://doi.org/10.1016/j.ygeno.2007.05.003
  11. Graff, J. E., & Herr, D. W. (2003). Disassociation of carbon disulfide-induced depression of flash-evoked poteitial peak N166 amplitude and norepinephrine levels. Toxicol Sci, 73(2), 403-415. https://doi.org/10.1093/toxsci/kfg072
  12. Haffner, S. M., Fong, D., Hazuda, H. P., Pugh, J. A., & Patterson, J. K. (1988). Hyperinsulinemia, upper body adiposity, and cardiovascular risk factors in nondiabetics. Metabolism, 37, 338-345. https://doi.org/10.1016/0026-0495(88)90133-3
  13. Khanna, V. K., Husain, R., & Seth, P. K. (1994). Effect of protein malnutrition on the neurobehavioural toxicity of styrene in young rats. J Appl Toxicol, 14, 351-356. https://doi.org/10.1002/jat.2550140506
  14. Kleinridders, A., Könner, A. C., & Brüning, J. C. (2009). CNS-targets in control of energy and glucose homeostasis. Current Opinion in Pharmacology, 9, 794-804. https://doi.org/10.1016/j.coph.2009.10.006
  15. Kohm, A. P., & Sanders, V. M. (2000). Norepinephrine: A messenger from the brain to the immune system. Immunology Today, 21(11), 539-542. https://doi.org/10.1016/S0167-5699(00)01747-3
  16. Kotseva, K., & Popov, T. (1998). Study of the cardiovascular effects of occupational exposure to organic solvents. Int Arch Occup Environ Health, 71, S87-S91.
  17. Landsberg, L., Troisi, R., & Parker, D. (1991). Obesity, blood pressure and the sympathetic nervous system. Am Epidemiol, 1, 295-303. https://doi.org/10.1016/1047-2797(91)90040-J
  18. Lima, J. J., Feng, H., Duckworth, L., Wang, J., Sylvester, J. E., Kissoon, N., & Garg, H. (2007). Association analyses of adrenergic receptor polymorphisms with obesity and metabolic alterations. Metabolism Clinical and Experimental, 56, 757-765. https://doi.org/10.1016/j.metabol.2007.01.007
  19. Marie, S., Luquet, S., Cutis, W., & Palmiter, R. D. (2005). Norepinephrine- and epinephrinedeficient mice gain weight normally on a high-fat diet. Obes Res, 13(9), 1518-1522. https://doi.org/10.1038/oby.2005.185
  20. Merker, G. H., Metzner, G., & Raabe, F. (2006). TH1-directed modulation of in vitro cytokine production in human peripheral blood mononuclear cells by styrene-7-8oxide. Toxicology letters, 160, 105-111. https://doi.org/10.1016/j.toxlet.2005.06.014
  21. Mutti, A., Falzoi, M., Romanelli, A., Bocchi, M. C., Ferroni, C., & Franchini, I. (1988). Brain dopamine as a target for solvent toxicity: Effects of some monocyclic aromatic hydrocarbons. Toxicol, 49, 77-82. https://doi.org/10.1016/0300-483X(88)90177-1
  22. National Cholesterol Education Program's Adult Treatment Panel III Report. (2002). Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults(Adults Treatment Panel III) final report. Circulation, 106, 3143-3421.
  23. NIOSH. (1996). NIOSH manual of analytical methods, 4th ed., Method 1051. Cincinnati: U.S. Department of Health and Human Services.
  24. Ogata, M., & Taguchi, T. (1988). Simultaneous determination of urinary creatinine and metabolites of toluene, xylene, ethylbenzene and phenol by automated high performance liquid chromatography. Int Arch Occup Environ, 61, 131-140. https://doi.org/10.1007/BF00381617
  25. Qiu, Y., Peng, Y., & Wang, J. (1996). Immunoregulatory role of neurotransmitters. Advances in Neuroimmunology, 6, 223-231. https://doi.org/10.1016/S0960-5428(96)00018-6
  26. Sepalainen, A. M., & Harkonen, H. (1976). Neurophysiological findings among workers occupationally exposed to styrene. Scand J Work Environ Health, 3, 140-46.
  27. Woods, S. C., & Seeley, R. J. (2005). Hormonal mediation of energy homeostasis in obesity, diabetes and related disorders. Drug Discovery Today: Disease Mechanisms, 2(3), 321-326. https://doi.org/10.1016/j.ddmec.2005.08.004